Lytix's drug candidate, LTX-315, is described in Bergensavisen today as 'a new promising medicine'.
A woman got rid of pain after treatment with LTX-315, the tumor shrunk and after 3 years it is still stable.
Read the article here (only in Norwegian)
E24 describes Lytix Biopharma as a 'cancer hope that has found the immune system's "gas pedal and GPS coordinates"'.
Read the article here (only in Norwegian, and behind paywall)